Register for Webinar on VTS-270 (2-hydroxypropyl-β-cyclodextrin) for NPC ~ Dateline: 12/07/2015
Register: US and Canadian Audience, 12:30 PM EST*, December 14, 2015
*9:30am Pacific, 10:30am Mountain, 11:30am Central, 12:30pm Eastern
Dear NNPDF Niemann-Pick Type C (NPC) Family Members,
The National Niemann-Pick Disease Foundation (NNPDF) is pleased to be able to share with you an opportunity to attend a town hall webinar hosted by Vtesse, Inc. with regards to the VTS-270 (2-hydroxypropyl-β-cyclodextrin) clinical trial for Niemann-Pick Disease, Type C (NPC).
Please join Vtesse on December 14, 2015 where Dr. Paul Gissen and Dr. Elizabeth Berry-Kravis will be providing an update on the clinical trial and will be available to address your questions. Vtesse is committed to keeping the community fully informed and soliciting feedback as they move through the clinical trial process.
Nadine M. Hill
National Niemann-Pick Disease Foundation